Issue link: http://www.e-digitaleditions.com/i/932381
March 12-13 in San Diego, CA, US, with two content streams: Development and formulation of inhaled therapies; and Inhalation devices: Product design and alternative therapeutic fields. Previewing the Inhalation & Respiratory Drug Delivery USA Congress 2018 Inhalation February 2018 7 When? March 12-13, 2018 Where? San Diego, CA, US For more information and registration: https://www.inhalationusa- congress.com/ The Inhalation & Respiratory Drug Delivery USA Congress 2018 will take place March 12-13 in San Diego, CA, US. Content will be p r e s e n t e d i n t w o i n t e r a c t i v e streams: Development and Formu- lation of Inhaled Therapies; and Inhalation Devices: Product Design and Alternative erapeutic Fields. Presentations Day one presentations will include immunomodulators, drug interac- tions, biopharmaceutics, interpar- ticle characterization, modeling, clinical efficacy, perfluorocarbon- based pulmonary delivery and realistic in vitro tests. Day two presentations will focus on digital inhalers, Faraday wave-based nebulizers, flow rate, particle engineering, modeling nasally administered drugs, new generation DPIs, generics, a soft mist insulin inhaler, cannabinoids, gene ther- apy, lentiviral vectors, heat-stable vaccines and intranasal devices. Additional events The event will be co-located with the Formulation and Drug Delivery USA Congress. In addition, the annual European-based event, "e Inhalation & Respiratory Drug Delivery Congress 2018" will be held May 8-9, 2018 in London UK. Driving Successful Drug Delivery by Bridging the Gaps between Patient Usage, Device Performance, and Formulation Learn more at: goproveris.com/labstudies F O R M U L A T I O N P A T I E N T U S A G E D E V I CE P E R F O R M A NCE